Recommendations for Dermatology Office Reopening in the Era of COVID-19.
J Drugs Dermatol
; 19(7): e1-e9, 2020 Jul 01.
Article
in English
| MEDLINE | ID: covidwho-690249
ABSTRACT
The COVID-19 pandemic, originating in Wuhan, China, has become a major public health and economic challenge for countries around the world. As of May 08, 2020, there are over 3 million COVID-19 cases, and 250,000 COVID-19- associated deaths in 215 countries. As more data is collected, updated infection control measures are continuously released and published by government, public health authorities, and physician specialty associations. Across the globe, dermatological practices have had to limit their operations to varying degrees to facilitate disease control, but as the pandemic subsides, they will broaden their operations. In light of the uncertainty surrounding safe and effective practice of medical and aesthetic dermatology in the era of COVID-19, fourteen international experts in the field contributed to recommendations for effective infection control protocols and practice management modifications. While guidance from the World Health Organization and local public health officials comes first, these recommendations are crafted as a starting point for dermatologists worldwide to commence either reopening their doors to patients or expanding available service offerings. This can help ensure that patients receive needed care in the short term and improve long term practice viability. J Drugs Dermatol. 2020;19(7)e-1-e-9. doi10.36849/JDD.2020.5293.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Physicians' Offices
/
Coronavirus Infections
/
Dermatology
/
Pandemics
Type of study:
Observational study
Limits:
Humans
Language:
English
Journal:
J Drugs Dermatol
Journal subject:
Dermatology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS